Susan Ph.D. Shiff - 17 Apr 2025 Form 4 Insider Report for Tvardi Therapeutics, Inc. (TVRD)

Role
Director
Signature
/s/ Dan Conn, Attorney-in-Fact
Issuer symbol
TVRD
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
21 Apr 2025, 17:15:17 UTC
Previous filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVRD Stock Option (right to buy) Award $0 +12,000 $0.000000 12,000 17 Apr 2025 Common Stock 12,000 $17.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable over three years in 12 equal quarterly installments commencing on July 17, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.